Harvard Bioscience to attend Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
HBIO•Harvard Bioscience will attend the forum on Nov. 11, 2026. CEO John Duke and CFO Mark Frost will hold one-on-one meetings, and Duke will join a panel at 9:30 a.m. ET.
1. Forum participation
Harvard Bioscience will attend Canaccord Genuity's MedTech, Diagnostics, and Digital Health and Services Forum on Nov. 11, 2026. CEO John Duke and CFO Mark Frost will participate in one-on-one meetings, and Duke will present on the “Emerging Tools for Research and Biopharma Use Cases” panel at 9:30 a.m. ET.
